Indeed, preclinical studies using animal models have demonstrated that deletion of the FKBP5 gene protects mice from diet-induced obesity and hepatic steatosis, and pharmacological inhibition of FKBP5 improves their metabolic health [41, 42]. This evidence concerns the gene FKBP5 and obesity due to melanocortin 4 receptor deficiency.